1. A One Health overview, facilitating advances in comparative medicine and translational research
- Author
-
Stroud, Cheryl, Dmitriev, Igor, Kashentseva, Elena, Bryan, Jeffrey N, Curiel, David T, Rindt, Hans, Reinero, Carol, Henry, Carolyn J, Bergman, Philip J, Mason, Nicola J, Gnanandarajah, Josephine S, Engiles, Julie B, Gray, Falon, Laughlin, Danielle, Gaurnier-Hausser, Anita, Wallecha, Anu, Huebner, Margie, Paterson, Yvonne, O’Connor, Daniel, Treml, Laura S, Stannard, James P, Cook, James L, Jacobs, Marc, Wyckoff, Gerald J, Likins, Lee, Sabbagh, Ubadah, Skaff, Andrew, Guloy, Amado S, Hays, Harlen D, LeBlanc, Amy K, Coates, Joan R, Katz, Martin L, Lyons, Leslie A, Johnson, Gayle C, Johnson, Gary S, O’Brien, Dennis P, Duan, Dongsheng, Calvet, James P, Gandolfi, Barbara, Baron, David A, Weiss, Mark L, Webster, Debra A, Karanu, Francis N, Robb, Edward J, and Harman, Robert J
- Subjects
Nursing ,Health Sciences ,Pediatric ,Rare Diseases ,Orphan Drug ,Vaccine Related ,Immunization ,Development of treatments and therapeutic interventions ,5.9 Resources and infrastructure (treatment development) ,Good Health and Well Being - Abstract
Table of contentsA1 One health advances and successes in comparative medicine and translational researchCheryl StroudA2 Dendritic cell-targeted gorilla adenoviral vector for cancer vaccination for canine melanomaIgor Dmitriev, Elena Kashentseva, Jeffrey N. Bryan, David T. CurielA3 Viroimmunotherapy for malignant melanoma in the companion dog modelJeffrey N. Bryan, David Curiel, Igor Dmitriev, Elena Kashentseva, Hans Rindt, Carol Reinero, Carolyn J. HenryA4 Of mice and men (and dogs!): development of a commercially licensed xenogeneic DNA vaccine for companion animals with malignant melanomaPhilip J. BergmanA5 Successful immunotherapy with a recombinant HER2-expressing Listeria monocytogenes in dogs with spontaneous osteosarcoma paves the way for advances in pediatric osteosarcomaNicola J. Mason, Josephine S. Gnanandarajah, Julie B. Engiles, Falon Gray, Danielle Laughlin, Anita Gaurnier-Hausser, Anu Wallecha, Margie Huebner, Yvonne PatersonA6 Human clinical development of ADXS-HER2Daniel O'ConnorA7 Leveraging use of data for both human and veterinary benefitLaura S. TremlA8 Biologic replacement of the knee: innovations and early clinical resultsJames P. StannardA9 Mizzou BioJoint Center: a translational success storyJames L. CookA10 University and industry translational partnership: from the lab to commercializationMarc JacobsA11 Beyond docking: an evolutionarily guided OneHealth approach to drug discoveryGerald J. Wyckoff, Lee Likins, Ubadah Sabbagh, Andrew SkaffA12 Challenges and opportunities for data applications in animal health: from precision medicine to precision husbandryAmado S. GuloyA13 A cloud-based programmable platform for healthHarlen D. HaysA14 Comparative oncology: One Health in actionAmy K. LeBlancA15 Companion animal diseases bridge the translational gap for human neurodegenerative diseaseJoan R. Coates, Martin L. Katz, Leslie A. Lyons, Gayle C. Johnson, Gary S. Johnson, Dennis P. O'BrienA16 Duchenne muscular dystrophy gene therapyDongsheng DuanA17 Polycystic kidney disease: cellular mechanisms to emerging therapiesJames P. CalvetA18 The domestic cat as a large animal model for polycystic kidney diseaseLeslie A. Lyons, Barbara GandolfiA19 The support of basic and clinical research by the Polycystic Kidney Disease FoundationDavid A. BaronA20 Using naturally occurring large animal models of human disease to enable clinical translation: treatment of arthritis using autologous stromal vascular fraction in dogsMark L. WeissA21 Regulatory requirements regarding clinical use of human cells, tissues, and tissue-based productsDebra A. WebsterA22 Regenerative medicine approaches to Type 1 diabetes treatmentFrancis N. KaranuA23 The zoobiquity of canine diabetes mellitus, man's best friend is a friend indeed-islet transplantationEdward J. RobbA24 One Medicine: a development model for cellular therapy of diabetesRobert J. Harman.
- Published
- 2016